Literature DB >> 11972078

Fluorescent tetracycline labeling as an aid to debridement of necrotic bone in the treatment of chronic osteomyelitis.

Laurence E Dahners1, Gary D Bos.   

Abstract

The authors have found that several months of preoperative tetracycline administration will label living bone so that it fluoresces under a blacklight during surgery. This allows intraoperative differentiation of viable bone from necrotic sequestra, which require removal in the treatment of chronic bone infection.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11972078     DOI： 10.1097/00005131-200205000-00009

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN： 0890-5339            Impact factor:   2.512


  10 in total

1.  Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.

Authors:  D Yoshiga; M Sasaguri; K Matsuo; S Kokuryou; M Habu; M Oda; M Kodama; H Tsurushima; O Sakaguchi; T Sakurai; J Tanaka; Y Morimoto; I Yoshioka; K Tominaga
Journal:  Osteoporos Int       Date:  2015-06-03       Impact factor: 4.507

2.  3D printed β-TCP bone tissue engineering scaffolds: Effects of chemistry on in vivo biological properties in a rabbit tibia model.

Authors:  Samit Kumar Nandi; Gary Fielding; Dishary Banerjee; Amit Bandyopadhyay; Susmita Bose
Journal:  J Mater Res       Date:  2018-07-27       Impact factor: 3.089

3.  Reconstruction of osteomyelitis defects.

Authors:  Paul Dinh; Brian K Hutchinson; Charalampos Zalavras; Milan V Stevanovic
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

4.  Use of a generic violet light in the surgical management of medication-related osteonecrosis of the jaws: a technical note.

Authors:  Caroline Ballardin; Cecilia Luiz Pereira-Stabile; Glaykon Alex Vitti Stabile
Journal:  Oral Maxillofac Surg       Date:  2018-09-01

Review 5.  Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.

Authors:  Yulin Chen; Xianmin Wu; Jiadong Li; Yingying Jiang; Ke Xu; Jiacan Su
Journal:  Front Pharmacol       Date:  2022-05-31       Impact factor: 5.988

6.  Feasibility of a tetracycline-binding method for detecting synovial fluid basic calcium phosphate crystals.

Authors:  Ann K Rosenthal; Mark Fahey; Claudia Gohr; Todd Burner; Irina Konon; Laureen Daft; Eric Mattson; Carol Hirschmugl; Lawrence M Ryan; Peter Simkin
Journal:  Arthritis Rheum       Date:  2008-10

7.  IGF-loaded silicon and zinc doped brushite cement: physico-mechanical characterization and in vivo osteogenesis evaluation.

Authors:  Sahar Vahabzadeh; Amit Bandyopadhyay; Susmita Bose; Rakesh Mandal; Samit Kumar Nandi
Journal:  Integr Biol (Camb)       Date:  2015-11-04       Impact factor: 2.192

8.  Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series.

Authors:  Ernesto Muñoz-Mahamud; Jenaro Ángel Fernández-Valencia; Andreu Combalia; Laura Morata; Álex Soriano
Journal:  J Bone Jt Infect       Date:  2021-01-27

9.  Influence of single and binary doping of strontium and lithium on in vivo biological properties of bioactive glass scaffolds.

Authors:  Pintu Kumar Khan; Arnab Mahato; Biswanath Kundu; Samit K Nandi; Prasenjit Mukherjee; Someswar Datta; Soumya Sarkar; Jayanta Mukherjee; Shalini Nath; Vamsi K Balla; Chitra Mandal
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 10.  The Therapeutic Effectiveness Using Fluorescence-Guided Surgery for MRONJ.

Authors:  Hongyuan Huang; Ning Zhao; Qingxiang Li; Qiao Qiao; Jianya Zhang; Chuanbin Guo; Yuxing Guo
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.